Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. Centers for Disease Control and Prevention. Department of Health and Human Services. Public Health Service. NGC:008694

Publication Details

Author(s):

• AHRQ (US) - Agency for Healthcare Research and Quality

Country(ies) of application:

• United States

Language(s):

• English

Type of Publication:

Guideline Clearing Report

Primary Contact:

Jean R. Slutsky, P.A., M.S.P.H.
jslutsky@ahrq.gov

Publication URL:

Open Publication URL in a new window

Publication Scope:

• Counselling
• Management
• Prevention
• Screening

Publication Status:

Published

Date of publication:

Sep 14, 2011

Due for Review:

-

Diseases / Conditions Addressed

MeSH Terms addressed:

• Sexually Transmitted Diseases (C01.539.780 / C02.800)
  • Sexually Transmitted Diseases, Viral (C02.800.801)
    • HIV Infections (C02.800.801.400)
• Immune System Disorders / Immunologic Diseases (C20)
  • Immunologic Deficiency Syndromes (C20.673)
    • HIV Infections (C20.673.480)
• Pharmacologic Actions (D27.505)
  • Anti-Retroviral Agents (D27.505.954.122.388.077)
• Female Genital Diseases and Pregnancy Complications (C13)
  • Pregnancy Complications (C13.703)
• Reproduction (G08.520)
  • Pregnancy (G08.520.769)
• Virus Infections (C02)
  • RNA Virus Infections (C02.782)
    • HIV Infections (C02.782.815.616.400)
• Pediatrics (G02.403.776.610)

Guideline key questions